Literature DB >> 31816350

The role of AhR in transcriptional regulation of immune cell development and function.

Prashant Trikha1, Dean A Lee2.   

Abstract

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcriptional factor (TF) that is a member of the Per-Arnt-Sim family of proteins. AhR regulates diverse processes, including malignant transformation, hematopoietic cell development, and fate determination of immune cell lineages. Moreover, AhR forms a crucial link between innate and adaptive arms of the immune system. Malignant cells frequently evolve multiple mechanisms for suppressing tumor-specific responses, including the induction of suppressive pathways involving AhR and its metabolic byproducts in the tumor microenvironment that promote immune evasion and tumor progression. Thus, interest is high in further defining the role of AhR in carcinogenesis and immune development and regulation, particularly regarding the therapeutic interventions that unleash immune responses to cancer cells. Here, we provide an overview of the role of AhR in the regulation of innate and adaptive immune response and discuss the implications of targeting this pathway to augment the immune response in cancer patients.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  AhR; Cancer immunity; Immune evasion; Immunotherapy; Natural killer cells

Mesh:

Substances:

Year:  2019        PMID: 31816350     DOI: 10.1016/j.bbcan.2019.188335

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  16 in total

Review 1.  New Topical Therapies in Development for Atopic Dermatitis.

Authors:  Egídio Freitas; Melinda Gooderham; Tiago Torres
Journal:  Drugs       Date:  2022-05-21       Impact factor: 9.546

2.  TDO2 and tryptophan metabolites promote kynurenine/AhR signals to facilitate glioma progression and immunosuppression.

Authors:  Chuanhong Zhong; Lilei Peng; Bei Tao; Senlin Yin; Liang Lyu; Hao Ding; Xiaobo Yang; Tangming Peng; Haiping He; Peizhi Zhou
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

3.  Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma.

Authors:  Soumen Khatua; Laurence J N Cooper; David I Sandberg; Leena Ketonen; Jason M Johnson; Michael E Rytting; Diane D Liu; Heather Meador; Prashant Trikha; Robin J Nakkula; Gregory K Behbehani; Dristhi Ragoonanan; Sumit Gupta; Aikaterini Kotrotsou; Tagwa Idris; Elizabeth J Shpall; Katy Rezvani; Rivka Colen; Wafik Zaky; Dean A Lee; Vidya Gopalakrishnan
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

Review 4.  How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression.

Authors:  Zhongyan Wang; Megan Snyder; Jessica E Kenison; Kangkang Yang; Brian Lara; Emily Lydell; Kawtar Bennani; Olga Novikov; Anthony Federico; Stefano Monti; David H Sherr
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 6.208

Review 5.  The Role of Aryl-Hydrocarbon Receptor (AhR) in Osteoclast Differentiation and Function.

Authors:  Robin Park; Shreya Madhavaram; Jong Dae Ji
Journal:  Cells       Date:  2020-10-14       Impact factor: 6.600

Review 6.  Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future.

Authors:  Margaret G Lamb; Hemalatha G Rangarajan; Brian P Tullius; Dean A Lee
Journal:  Stem Cell Res Ther       Date:  2021-03-25       Impact factor: 6.832

7.  AHR Regulates NK Cell Migration via ASB2-Mediated Ubiquitination of Filamin A.

Authors:  June Ho Shin; Uriel Y Moreno-Nieves; Luhua H Zhang; Chen Chen; Amera L Dixon; Miles H Linde; Emily M Mace; John B Sunwoo
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

8.  Defining the AHR-regulated transcriptome in NK cells reveals gene expression programs relevant to development and function.

Authors:  Prashant Trikha; Jena E Moseman; Aarohi Thakkar; Amanda R Campbell; Ezgi Elmas; Jennifer A Foltz; Nitin Chakravarti; James R Fitch; Elaine R Mardis; Dean A Lee
Journal:  Blood Adv       Date:  2021-11-23

Review 9.  Circadian Host-Microbiome Interactions in Immunity.

Authors:  Thomas D Butler; Julie E Gibbs
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

Review 10.  Epigenetic Regulations of AhR in the Aspect of Immunomodulation.

Authors:  Anna Wajda; Joanna Łapczuk-Romańska; Agnieszka Paradowska-Gorycka
Journal:  Int J Mol Sci       Date:  2020-09-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.